Showing results (101-110 of 219) with videos related to
Sort By:
Pageof 22
Neurobiology of Learning and Memory|February 20, 2003
Peripheral 8-OH-DPAT and scopolamine infused into the frontal cortex produce passive avoidance retention impairments in ratsAnthony C Santucci, Christina ShawCanadian Journal on Aging = La Revue Canadienne Du Vieillissement|September 14, 2019
Perspectives about Interprofessional Collaboration and Patient-Centred CareSherry Dahlke, Kathleen F Hunter, Maya Reshef Kalogirou, et al.Neurourology and Urodynamics|March 6, 2013
Long-term safety, tolerability and efficacy of flexible-dose fesoterodine in elderly patients with overactive bladder: open-label extension of the SOFIA trialAdrian Wagg, Vik Khullar, Martin C Michel, et al.Journal of Medical Economics|March 14, 2017
Clinical and economic impact of mirabegron compared with antimuscarinics for the treatment of overactive bladder in CanadaZalmai Hakimi, Jameel Nazir, Charles McCrea, et al.Age and Ageing|March 16, 2007
National audit of continence care for older people: management of faecal incontinenceJonathan Potter, Penny Peel, Sarah Mian, et al.Age and Ageing|June 21, 2019
Long-term effect of community-based continence promotion on urinary symptoms, falls and healthy active life expectancy among older women: cluster randomised trialCara Tannenbaum, Xavier Fritel, Alex Halme, et al.European Urology|November 18, 2019
Efficacy, safety, and tolerability of mirabegron in patients aged ≥65yr with overactive bladder wet: a phase IV, double-blind, randomised, placebo-controlled study (PILLAR)Adrian Wagg, David Staskin, Eli Engel, et al.Journal of Wound, Ostomy, and Continence Nursing : Official Publication of the Wound, Ostomy and Continence Nurses Society|September 13, 2019
Toileting Disability in Older People Residing in Long-term Care or Assisted Living Facilities: A Scoping Review of the LiteratureJasper Yeung, Allyson Jones, Gian S Jhangri, et al.Pharmacoeconomics - Open|February 15, 2018
Economic Impact of Mirabegron Versus Antimuscarinics for the Treatment of Overactive Bladder in the UKJameel Nazir, Malin Berling, Charles McCrea, et al.Current Medical Research and Opinion|February 2, 2016
Oral pharmacotherapy for overactive bladder in older patients: mirabegron as a potential alternative to antimuscarinicsAdrian Wagg, Victor W Nitti, Con Kelleher, et al.Pageof 22